Philippines Business News

2026 China Fuzhou International Investment Promotion Month and the 28th Cross-Strait Fair for Economy and Trade Held in Fuzhou, Fujian Province

FUZHOU, China, May 22, 2026 (GLOBE NEWSWIRE) -- The 2026 China Fuzhou International Investment Promotion Month and the 28th Cross-Strait Fair for Economy and Trade (hereinafter referred to as the "Investment Promotion Month and Cross-Strait Fair") are being held in Fuzhou, Fujian Province, from May 21 to June 21. On the morning of May 22, the opening ceremony of the 28th Cross-Strait Fair for Economy and Trade was held. That afternoon, the launch ceremony of the 2026 China Fuzhou International I

Results of refinancing - Nykredit Realkredit A/S

To Nasdaq Copenhagen and the Press Results of refinancing The Nykredit Group has completed the auctions in connection with the refinancing of ARMs based on the "refinancing price" principle. The interest rates will be reset on 1 July 2026. The interest rate reset results in the following cash rates: ARMs funded by 1Y SDO (April 2027) DKK ARMs funded by 3Y SDO (July 2029) DKK ARMs funded by 5Y SDO (July 2031) DKK Cash rate 2.85%2.88%3.00% For detailed information on the auction results, please re

Results of refinancing - Totalkredit A/S

To Nasdaq Copenhagen and the Press Results of refinancing The Nykredit Group has completed the auctions in connection with the refinancing of ARMs based on the "refinancing price" principle. The interest rates will be reset on 1 July 2026. The interest rate reset results in the following cash rates: ARMs funded by 1Y SDO (April 2027) DKK ARMs funded by 3Y SDO (July 2029) DKK ARMs funded by 5Y SDO (July 2031) DKK Cash rate 2.85%2.88%3.00% For detailed information on the auction results, please re

Shanxi Qinyuan: Lingkong Mountain Scenic Area will usher in Peak Tourist Season

CHANGZHI, China, May 22, 2026 (GLOBE NEWSWIRE) -- Since the "May Day" holiday, the Lingkong Mountain Scenic Area, nestled deep in the Taiyue Mountains of Qinyuan County, has experienced a significant surge in tourism. Along the access roads, self-driving tourists queued in an orderly manner and were guided by staff into designated parking areas. Families and groups of friends could be seen enjoying their outings amid a lively holiday atmosphere. Qinyuan County Cultural Tourism Bureau noted that

Man Group PLC : Form 8.3 - DCC Plc

Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloserMan Group PLC(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a) The naming of nominee or vehicle companies isinsufficient. For a trust, the trustee(s), settlor andbeneficiaries must be n

Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 21 05 2026] - (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari

Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced the pricing of an underwritten, registered offering (the offering) of an aggregate of 3,358,602 shares of common stock at an offering price per share of common stock of $26.50, and, to certain investors in lieu of common stock, pre-funded warrants to purchase up to 415,000 sh

Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 21 04 2026] - (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be

Chagee to Announce First Quarter 2026 Financial Results on May 28, 2026

SHANGHAI, May 22, 2026 (GLOBE NEWSWIRE) -- Chagee Holdings Limited (NASDAQ: CHA) ("Chagee” or the "Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks, today announced that it plans to report its financial results for the first quarter ended March 31, 2026, after the U.S. market closes on May 28, 2026. The Company’s management team will hold a conference call at 9:00 P.M. U.S. Eastern Time on Thursday, May 28, 2026 (or 9:00 A.M. Hong Kong Time on F

Synack Highlights Human + AI Continuous Security Validation at the Gartner Security & Risk Management Summit

Live demos and expert sessions will showcase how organization close the 68% security coverage gap in the age of AI NATIONAL HARBOR, Md., May 22, 2026 (GLOBE NEWSWIRE) -- GARTNER SECURITY & RISK MANAGEMENT SUMMIT -- Synack, provider of a Human + AI platform for continuous security validation, today announced it is exhibiting in the Gartner Security & Risk Management Summit 2026, happening June 1-3, 2026 in National Harbor, MD. Throughout the event, Synack will demonstrate how organizations are co

Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet

Base shelf prospectus is accessible on SEDAR+ NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO and HOUSTON, May 22, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna” or the ”Company”) (TSX: MDNA), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, announced today that, in connection with its previously announced marketed public offering (the "Offering”) of uni

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

- Phase 2 study in cholestatic liver diseases, focused on PBC and PSC, anticipated to initiate in Q1 2027 - - Builds on completed Phase 1a study and ongoing development in HDV - SOUTH SAN FRANCISCO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced plans to expand the clinical development of ABI-6250, its oral entry inhibitor candidate for chronic hepatit

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026

SAN FRANCISCO, May 22, 2026 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, today announced that its Annual Meeting of Shareholders will be held on June 24, 2026, at 9:00 a.m. CT. The Annual Meeting will be a virtual meeting via a live audio webcast that is available at: www.virtualshareholdermeeting.com/AMS2026. There will be no physical

BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor

Strengthening balance sheet on path to Nasdaq uplisting POMPANO BEACH, Fla., May 22, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc.(OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entered into a securities purchase agreement (the "Securities Purchase Agreement”) with its first institutional investor for the purchase and sale of 746,269 shares of common stock at

Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi

Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across Europe CINCINNATI, May 22, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System (OBDS), today announced CE Certification of its enFuse on-body injector and syringe transfer system for use in combination with Aspaveli® (pegcetacoplan). The enFuse OBDS will be commercialized as ASPAV

Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss

TARRYTOWN, N.Y., May 22, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the European Medicines Agency (EMA) has accepted for review under Accelerated Assessment the Marketing Authorization Application (MAA) for Otarmeni™ (lunsotogene parvec), an in vivo adeno-associated virus vector-based gene therapy for the treatment of biallelic OTOF variant-associated hearing loss. Otarmeni, formerly known as DB-OTO, previously received Orphan Designation from the EMA

Aben Gold Corp. Receives 5-Year Class 3 Quartz License at Justin Gold Tungsten Project, Yukon

Vancouver, BC, May 22, 2026 (GLOBE NEWSWIRE) -- Aben Gold Corp. (TSX-V: ABM) (OTCID: ABNAF) (Frankfurt: ML1) ("Aben” or "the Company”) is pleased to announce that it has received a Class 3 Quartz Mining Land Use Approval from the Yukon Government’s Department of Energy, Mines & Resources for its 100%-owned Justin Gold Tugnsten Project in southeast Yukon.The approval is effective as of yesterday, May 21, 2026, and is valid for five years until May 20, 2031. It authorizes a comprehensive suite of

Destination XL Group, Inc. to Review Unsolicited Tender Offer From Zodiac Partners II

No Shareholder Action Required at this Time CANTON, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. ("DXL”) (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, today issued the following statement with respect to the unsolicited $0.82 per share in cash tender offer (the "Offer”) made by Zodiac Partners II, LLC ("Zodiac") on May 12, 2026: The DXL Board of Directors is carefully evaluating the Offer with its independent financial and

Concorde International Group Proprietary Security Model Featured on World FM Day 2026

SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Concorde International Group Ltd. (NASDAQ: YOOV) (the "Company”), an integrated provider of technology-enabled security solutions, today highlighted its continued recognition in the facilities security industry, reflecting more than a decade of leadership in delivering comprehensive security services through its proprietary operational model. The Company was recently featured in the official World FM Day 2026 commemorative video by the Singapore Intern

Lula leads Flavio Bolsonaro in latest Brazil presidential race poll

RBI to transfer 2.87 trillion rupees surplus to Indian government

Germany to spend over 4% of GDP on defense, eyes 5% target

German business morale rises unexpectedly in May, Ifo survey shows

USTR Greer says USMCA talks next week to focus on content rules